drugset / Trial / NCT06819553

A Randomized Clinical Trial to Evaluate the Effectiveness of Oral Potassium Citrate in Preventing Ureteral Stent Encrustation in Patients Undergoing Ureteroscopy for Uric Acid Kidney Stones

NCT06819553

Phase 2/3 Active not recruiting 48 enrolled Zagazig University
RandomizedParallel-groupSingle-blindPrevention

Summary

This randomized clinical trial aims to evaluate the efficacy of oral potassium citrate in reducing ureteral stent encrustation following ureteroscopy for uric acid kidney stones. The study will assess whether potassium citrate, by raising urinary pH, can prevent encrustation on stents, potentially improving patient outcomes and reducing complications.

Timeline

Start
2024-11-03
Primary completion
2025-02-01
Completion
2025-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject POTASSIUM CITRATE ANHYDROUS Small molecule 15 meq Oral